Meta-analysis of observational studies Nicole Vogelzangs Department of Psychiatry & EMGO + institute.

Slides:



Advertisements
Similar presentations
Case-control study 3: Bias and confounding and analysis Preben Aavitsland.
Advertisements

How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
M2 Medical Epidemiology
Meta-analysis: summarising data for two arm trials and other simple outcome studies Steff Lewis statistician.
Associations between Obesity and Depression by Race/Ethnicity and Education among Women: Results from the National Health and Nutrition Examination Survey,
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2009.
Writing a Research Protocol Michael Aronica MD Program Director Internal Medicine-Pediatrics.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
Journal Club Alcohol and Health: Current Evidence May-June 2006.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Journal Club Alcohol and Health: Current Evidence January-February 2005.
Journal Club Alcohol and Health: Current Evidence September-October 2005.
BS704 Class 7 Hypothesis Testing Procedures
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Thomas Songer, PhD Introduction to Research Methods In the Internet Era Critically Reviewing an Epidemiologic Study.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 12: Multiple and Logistic Regression Marshall University.
EPIDEMIOLOGY Why is it so damn confusing?. Disease or Outcome Exposure ab cd n.
Are the results valid? Was the validity of the included studies appraised?
Study Design / Data: Case-Control, Descriptives Basic Medical Statistics Course: Module C October 2010 Wilma Heemsbergen
Cohort Study.
Unit 6: Standardization and Methods to Control Confounding.
HSTAT1101: 27. oktober 2004 Odd Aalen
Multiple Choice Questions for discussion
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
Research Study Design and Analysis for Cardiologists Nathan D. Wong, PhD, FACC.
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
Biostatistics Case Studies 2005 Peter D. Christenson Biostatistician Session 4: Taking Risks and Playing the Odds: OR vs.
TWO-STAGE CASE-CONTROL STUDIES USING EXPOSURE ESTIMATES FROM A GEOGRAPHICAL INFORMATION SYSTEM Jonas Björk 1 & Ulf Strömberg 2 1 Competence Center for.
Lecture 17 (Oct 28,2004)1 Lecture 17: Prevention of bias in RCTs Statistical/analytic issues in RCTs –Measures of effect –Precision/hypothesis testing.
Biostatistics Case Studies Peter D. Christenson Biostatistician Session 5: Analysis Issues in Large Observational Studies.
Estimation of overweight-attributable deaths Katherine M. Flegal, Ph.D. Centers for Disease Control and Prevention National Center for Health Statistics.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
POTH 612A Quantitative Analysis Dr. Nancy Mayo. © Nancy E. Mayo A Framework for Asking Questions Population Exposure (Level 1) Comparison Level 2 OutcomeTimePECOT.
Design and Analysis of Clinical Study 11. Analysis of Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Simon Thornley Meta-analysis: pooling study results.
A short introduction to epidemiology Chapter 2b: Conducting a case- control study Neil Pearce Centre for Public Health Research Massey University Wellington,
Lecture 7 Objective 18. Describe the elements of design of observational studies: case ‑ control studies (retrospective studies). Discuss the advantages.
The Campbell Collaborationwww.campbellcollaboration.org C2 Training: May 9 – 10, 2011 Introduction to meta-analysis.
Contingency tables Brian Healy, PhD. Types of analysis-independent samples OutcomeExplanatoryAnalysis ContinuousDichotomous t-test, Wilcoxon test ContinuousCategorical.
Case-control study Chihaya Koriyama August 17 (Lecture 1)
MBP1010 – Lecture 8: March 1, Odds Ratio/Relative Risk Logistic Regression Survival Analysis Reading: papers on OR and survival analysis (Resources)
Osteoarthritis Initiative Analytic Strategies for the OAI Data December 6, 2007 Charles E. McCulloch, Division of Biostatistics, Dept of Epidemiology and.
1 Risk Assessment Tests Marina Kondratovich, Ph.D. OIVD/CDRH/FDA March 9, 2011 Molecular and Clinical Genetics Panel for Direct-to-Consumer (DTC) Genetic.
Causal relationships, bias, and research designs Professor Anthony DiGirolamo.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Going from data to analysis Dr. Nancy Mayo. Getting it right Research is about getting the right answer, not just an answer An answer is easy The right.
1 Multivariable Modeling. 2 nAdjustment by statistical model for the relationships of predictors to the outcome. nRepresents the frequency or magnitude.
BC Jung A Brief Introduction to Epidemiology - XIII (Critiquing the Research: Statistical Considerations) Betty C. Jung, RN, MPH, CHES.
Matching. Objectives Discuss methods of matching Discuss advantages and disadvantages of matching Discuss applications of matching Confounding residual.
POPLHLTH 304 Regression (modelling) in Epidemiology Simon Thornley (Slides adapted from Assoc. Prof. Roger Marshall)
Instrument design Essential concept behind the design Bandit Thinkhamrop, Ph.D.(Statistics) Department of Biostatistics and Demography Faculty of Public.
Is a meta-analysis right for me? Jaime Peters June 2014.
How to Conduct a Meta-Analysis Arindam Basu MD MPH About the Author Required Browsing.
Approaches to quantitative data analysis Lara Traeger, PhD Methods in Supportive Oncology Research.
1 Study Design Imre Janszky Faculty of Medicine, ISM NTNU.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 13: Multiple, Logistic and Proportional Hazards Regression.
Week Seven.  The systematic and rigorous integration and synthesis of evidence is a cornerstone of EBP  Impossible to develop “best practice” guidelines,
Measures of disease frequency Simon Thornley. Measures of Effect and Disease Frequency Aims – To define and describe the uses of common epidemiological.
Methodological quality assessment of observational studies Nicole Vogelzangs Department of Psychiatry & EMGO + institute.
Lecture 1: Fundamentals of epidemiologic study design and analysis
Coffee drinking and leukocyte telomere length: A meta-analysis
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Narrative Reviews Limitations: Subjectivity inherent:
Presentation transcript:

Meta-analysis of observational studies Nicole Vogelzangs Department of Psychiatry & EMGO + institute

Outline RCTs vs. observational studies Data extraction Meta-analysis –Combining results (statistical pooling) –Studying sources of heterogeneity (subgroup analysis and meta-regression analysis) Observational II-2

RCT vs. observational research hypothesis therapyetiology, diagnosis, prognosis methodology cleardivers, different designs validity design highvarying risk of confounding lowhigh analyses clearadjustment for confounding univariablemultivariable RCT Observational research Observational II-3

Heterogeneity More heterogeneity in observational studies compared with RCTs: –Design –Population (less strict selection criteria) –Different ways of assessing exposure and disease –Adjustment for confounding Studying the sources of heterogeneity is an important aim of analyses in reviews of observational studies Observational II-4

An example Depression as a risk factor for the onset of type 2 diabetes mellitus - Knol, Twisk et al. Diabetologica 2006 Selection criteria –Longitudinal studies on depression and onset of DM2 –Exclusion: studies including prevalent DM2 cases (only persons ‘at risk’) Insufficient data to calculate RR, OR or HR Observational II-5

Publication bias? Studies with large SE (small N) and weaker association appear absent Observational II-6

Outline RCTs vs. observational studies Data extraction Meta-analysis –Combining results (statistical pooling) –Studying sources of heterogeneity (subgroup analysis and meta-regression analysis) Observational II-7

Data extraction For each study: 1.Effect estimate (association determinant – outcome) For confounding corrected effect! 2.Variance or standard error (SE) of the effect estimate (=> weight in meta-analysis) 3.Information on potential sources of heterogeneity Observational II-8

1. Effect estimate Effect estimate based on multivariable analysis, adjusted for all possible confounders (age, sex, BMI, blood pressure, etc.) Cohort study: –Logistic regression: OR –Cox regression: hazard ratio (HR ≈ RR) Patient-control study –Logistic regression: OR Observational II-9

Are OR and RR/HR exchangeable? Only when risk of outcome is small! Odds = p / 1-p large risk, e.g. p=0.30: odds = 0.30 / 0.70 = 0.43 small risk, e.g. p=0.01: odds = 0.01 / 0.99 ≈ 0.01 => when risk is large, OR is overestimation of RR alcohol consumption - bladder cancer: OR is OK computer job - neck/shoulder complaints: OR not OK Observational II-10

2. Standard error of the effect estimate SE often not reported Calculate from –confidence interval –p-value (need sufficient decimals; p <.05 is insufficient) Observational II-11

3. Sources of heterogeneity Characteristics of study population Method of measurement for exposure to risk factor / prognostic factor Method of measurement outcome or disease Aspects of design Analysis Observational II-12

Sources of heterogeneity - example Population: differences in age, gender, potential confounders Measurement of exposure: method for assessment of depression (questionnaire, interview, diagnosis care provider) Outcome: method for assessment diabetes (screening or self-report) Observational II-13

Sources of heterogeneity - example Aspects of design: cohort study –Duration of follow-up? –Response / drop-out rate? –Which confounders are measured? –Which methods are used to exclude diabetes patients at baseline? Analysis –How is exposure defined? (score on depression scale or dichotomous [cut-off]) –Which confounders are used in analysis? Observational II-14

Reducing heterogeneity Some study differences can be canceled out by converting published data: –Defining exposure (e.g. merge several depression categories into yes/no depression) –Degree of adjustment for confounding => Possibilities strongly depend on reporting Observational II-15

Outline RCTs vs. observational studies Data extraction Meta-analysis –Combining results (statistical pooling) –Studying sources of heterogeneity (subgroup analysis en meta-regression analysis) Observational II-16

Meta-analysis Combining results (statistical pooling) Enter for each study: –effect estimate –weight (1 / SE 2 ) Fixed effects model (often not realistic) Random effects model Study influence of sources of heterogeneity –Subgroup analysis –Meta-regression analysis Observational II-17

Meta-analysis - example RR (REM): 1.37 ( ) Q-test: p = 0.02 Observational II-18

Study heterogeneity: subgroup analysis 1 characteristic at once (e.g. duration of follow-up) Not too many categories (e.g. > or < 5 year) Stratify for these categories Pool effect estimates within each category Observational II-19

Subgroup analysis - example RR Yes (n = 3)No (n = 6) Exclusion undetected diabetes at baseline Observational II-20

Study heterogeneity: meta-regression Several characteristics can be studied simultaneously (e.g. follow-up duration, design type, age of population) Efficient and more power Also possible for ordinal and continuous measures Observational II-21

Meta-regression What is meta-regression? Weighted linear regression Studies are subject of analysis Dependent variable (Y) = effect estimate of study Weight = 1 / SE 2 Independent variables (X) = sources of heterogeneity (effect modifiers) Y = b 0 + b 1 X + unexplained variance Observational II-22

Dependent variable (outcome) Linear regression: dependent variable (Y) should be +/- normally distributed OR en RR: skewed distribution Log-transformation:ln (OR) = b 0 + b 1 X ln (RR) = b 0 + b 1 X Observational II-23

Meta-regression: sleep position and sudden infant death Year of study 0 0,5 1,0 1,5 2,0 2,5 3, ln(OR) stomach vs. back Observational II-24

Meta-regression: depression and incidence of diabetes No association between duration of follow-up and effect estimate Observational II-25

Meta-regression (fictive data) Association depression and incidence diabetes 6 (fictive) cohort studies 3 studies adjust for overweight (BMI > 25), 3 do not adjust for BMI Enter for each study: –ln (RR) –weighting factor: 1 / SE 2 –confounder adjustment (yes = 1, no = 0) Observational II-26

Meta-regression - example Regression equation: ln(RR) = b 0 + b 1 * adjconf Results regression analysis (output) b 0 = 0.750, b 1 = Pooled ln(RR) for studies without adjustment for overweight (adjconf = 0) ln(RR) = (-0.250*0) = => RR = e = 2.11 Pooled ln(RR) for studies with adjustment for overweight (adjconf = 1) ln(RR) = (-0.250*1) = => RR = e = 1.65 Observational II-27

Bottlenecks meta-regression I Limited number of variables that can be studied at once: usually limited number of studies Necessary data are not always available Ecological fallacy (aggregation bias): Associations are analyzed at aggregated level: do not necessarily reflect the true association within studies Observational II-29

Ecological fallacy Effect of age within studies, not found when analyzed at aggregated level See: Thompson SG & Higgins JPT. Stat Med 2002;21: No effect of age within studies, effect found when analyzed at aggregated level Observational II-30

Bottlenecks meta-regression II For subgroup analyses and meta-regression: studying more variables increases risk of type I error (false-positive results) Restrict the number of subgroups / variables: –Hypothesis testing: a priori analyses: describe in methods –Hypothesis generating: post hoc analyses: discuss in discussion Observational II-31

Individual patient data (IPD) meta-analysis The best solution? –Request all original data –Clean data and recode if necessary –Meta-analysis and subgroup analysis / meta-regression –Very powerful –Cheaper than new trials But: –Very labor intensive –Data sometimes (often?) no longer available Observational II-33

In sum Meta-analysis of observational studies –Large heterogeneity –Prework necessary Statistical analysis –Statistical pooling: fixed/random effects model –Analysis of sources of heterogeneity (subgroup analysis, meta-regression) –IPD meta-analysis Keep in mind limitations of subgroup analysis / meta-regression! Observational II-34

Meta-analysis of observational studies THE END Observational II-35